Showing results (481-490 of 569) with videos related to

Sort By:
Pageof 57
Human Immunology|August 1, 1991
HLA antigens influence resistance to lung carcinomaP J Romano, M Bartholomew, P J Smith, et al.
Clinical Nutrition ESPEN|November 13, 2020
Reducing 30-day post gastrostomy insertion mortality with a feeding issues multidisciplinary team meetingA Bond, T Conley, J Fiske, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?D M Barnes, J Bartkova, R S Camplejohn, et al.
Diabetes|September 2, 2000
Oxygen consumption oscillates in single clonal pancreatic beta-cells (HIT)D M Porterfield, R F Corkey, R H Sanger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2001
Suppression of granulocyte-macrophage colony-stimulating factor expression by glucocorticoids involves inhibition of enhancer function by the glucocorticoid receptor binding to composite NF-AT/activator protein-1 elementsP J Smith, D J Cousins, Y K Jee, et al.
British Journal of Urology|December 1, 1979
The role of selective internal urethrotomy in the management of urethral stricture: a multi-centre evaluationC G Gaches, M H Ashken, M Dunn, et al.
Oncogene|March 7, 1996
A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell linesE M Algar, T Khromykh, S I Smith, et al.
Human Mutation|January 1, 1995
Homozygous intragenic deletion in the WT1 gene in a sporadic Wilms' tumour associated with high levels of expression of a truncated transcriptE M Algar, M T Kenney, L A Simms, et al.
Equine Veterinary Journal|January 1, 1997
Visual outcome and ocular survival following iris prolapse in the horse: a review of 32 casesN T Chmielewski, D E Brooks, P J Smith, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 11, 1999
Recent bioequivalence studies on fixed-dose combination anti-tuberculosis drug formulations available on the global marketG Pillai, P B Fourie, N Padayatchi, et al.
Pageof 57